NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM) securities during the period from October 31, 2022, through August 2, 2024 ("the Class Period"). Investors have until May 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit ...